MabCampath

alemtuzumab · Genzyme

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MabCampath, covering 2012-08-10 to 2023-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath [Phase 2]